Prognostic role of Helicobacter pylori infection in acute coronary syndrome: a prospective cohort study

R Eskandarian, R Ghorbani, M Shiyasi, B Momeni, K Hajifathalian, M Madani, R Eskandarian, R Ghorbani, M Shiyasi, B Momeni, K Hajifathalian, M Madani

Abstract

In a prospective cohort study, we evaluated the effect of Helicobacter pylori seropositivity on the risk of future adverse cardiovascular outcomes among patients with acute coronary syndrome (ACS). In 433 patients, IgA and IgG antibodies to H pylori, along with classic risk factors, including hypertension, diabetes, hyperlipidaemia, smoking and family history of coronary artery disease (CAD) were determined. Short and long-term follow-up information on adverse outcomes, defined as recurrence of unstable angina, myocardial infarction, coronary angioplasty, coronary artery bypass graft surgery, and sudden cardiac death was obtained. None of the classic CAD risk factors correlated with incidence of either short- or long-term outcomes. Seropositivity for H pylori was significantly associated with risk of short-term adverse outcomes, and independently predicted their incidence in multivariate regression (R = 3.05, p < 0.001). Results failed to show such an association between H pylori seropositivity and long-term adverse outcomes. H pylori infection may affect short-term prognosis in patients with ACS. Randomised trials are needed to evaluate the role of H pylori eradication in these patients.

References

    1. Mirat J. Physical activity in the prevention and treatment of cardiovascular diseases. Acta Med Croatica. 2007;61(Suppl 1):63–67.
    1. Pellicano R, Oliaro E, Rizzetto M, Ponzetto A. Infections and cardiovascular diseases on an ischemic basis. The case of Helicobacter pylori. Minerva Med. 2000;91:161–167.
    1. Pellicano R. et al. Patients with acute myocardial infarction in northern Italy are often infected by Helicobacter pylori. Panminerva Med. 1999;41:279–282.
    1. Pellicano R, Parravicini PP, Bigi R, La Rovere MT, Baduini G, Gandolfo N. et al. Updated review (2006) on Helicobacter pylori as a potential target for the therapy of ischemic heart disease. Panminerva Med. 2006;48:241–246.
    1. Szklo M, Ding J, Tsai MY, Cushman M, Polak JF, Lima J. et al. Individual pathogens, pathogen burden and markers of subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. J Cardiovasc Med (Hagerstown) 2009;10:747–751.
    1. Sheehan J, Kearney PM, Sullivan SO, Mongan C, Kelly E, Perry IJ. Acute coronary syndrome and chronic infection in the Cork coronary care case-control study. Heart. 2005;91:19–22.
    1. Famularo G, Trinchieri V, Santini G, De Simone C. Infections, atherosclerosis, and coronary heart disease. Ann Ital Med Int. 2000;15:144–155.
    1. Tamer GS, Tengiz I, Ercan E, Duman C, Alioglu E, Turk UO. Helicobacter pylori seropositivity in patients with acute coronary syndromes. Dig Dis Sci. 2009;54:1253–1256.
    1. Miyazaki M, Babazono A, Kadowaki K, Kato M, Takata T, Une H. Is Helicobacter pylori infection a risk factor for acute coronary syndromes? J Infect. 2006;52:86–91.
    1. Lee SY, Kim DK, Son HJ, Lee JH, Kim YH, Kim JJ. et al. The impact of Helicobacter pylori infection on coronary heart disease in a Korean population. Korean J Gastroenterol. 2004;44:193–198.
    1. Aceti A, Are R, Sabino G, Fenu L, Pasquazzi C, Quaranta G. et al. Helicobacter pylori active infection in patients with acute coronary heart disease. J Infect. 2004;49:8–12.
    1. Kahan T, Lundman P, Olsson G, Wendt M. Greater than normal prevalence of seropositivity for Helicobacter pylori among patients who have suffered myocardial infarction. Coron Artery Dis. 2000;11:523–526.
    1. Rechciński T, Kasprzak JD, Chmiela M, Krzemińska-Pakuła M, Rudnicka W. Patients with unstable angina pectoris present increased humoral response against Helicobacter pylori in comparison with patients with aggravated dyspepsia. Acta Microbiol Pol. 2002;51:339–344.
    1. Ammann P, Marschall S, Kraus M, Schmid L, Angehrn W, Krapf R, Rickli H. Characteristics and prognosis of myocardial infarction in patients with normal coronary arteries. Chest. 2000;117:333–338.
    1. Murray LJ, Bamford KB, O’Reilly DP, McCrum EE, Evans AE. Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class. Br Heart J. 1995;74:497–501.
    1. Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N. et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br Med J. 1995;311:711–714.
    1. Stone AF, Mendall MA. Helicobacter pylori is an aetiological factor for ischaemic heart disease: the case in favour. Dig Liver Dis. 2000;32:62–64.
    1. Stone AF, Mendall MA, Kaski JC, Edger TM, Risley P, Poloniecki J. et al. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA). Circulation. 2002;106:1219–1223.
    1. Rathbone B, Martin D, Stephens J, Thompson JR, Samani NJ. Helicobacter pylori seropositivity in subjects with acute myocardial infarction. Heart. 1996;76:308–311.
    1. Strachan DP, Mendall MA, Carrington D, Butland BK, Yarnell JW, Sweetnam PM, Elwood PC. Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the Caerphilly prospective heart disease study. Circulation. 1998;98:1286–1290.
    1. Choussat R, Montalescot G, Collet J, Jardel C, Ankri A, Fillet A. et al. Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction. Am J Cardiol. 2000;86:379–384.
    1. Zhu J, Quyyumi AA, Muhlestein JB, Nieto FJ, Horne BD, Zalles-Ganley A. et al. Lack of association of Helicobacter pylori infection with coronary artery disease and frequency of acute myocardial infarction or death. Am J Cardiol. 2002;89:155–158.
    1. Murray LJ, Bamford KB, Kee F, McMaster D, Cambien F, Dallongeville J, Evans A. Infection with virulent strains of Helicobacter pylori is not associated with ischaemic heart disease: evidence from a populationbased case-control study of myocardial infarction. Atherosclerosis. 2000;149:379–385.
    1. Figura N, Palazzuoli A, Faglia S, Lenzi C, Borrello F, Palazzuoli V. et al. Infection by CagA-positive Helicobacter pylori strains in patients with ischemic heart disease: prevalence and association with exerciseinduced electrocardiographic abnormalities. Dig Dis Sci. 2002;47:831–836.
    1. Franceschi F, Navarese EP, Mollo R, Giupponi B, De Marco G, Merra G. et al. Helicobacter pylori and atherosclerosis. A review of the literature. Recenti Prog Med. 2009;100:91–96.
    1. Ridker PM, Danesh J, Youngman L, Collins R, Stampfer MJ, Peto R, Hennekens CH. A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U.S. men. Ann Intern Med. 2001;135:184–188.
    1. Pellicano R, Oliaro E, Mangiardi L, Orzan F, Bergerone S, Gandolfo N. et al. Ischemic cardiovascular diseases. Correlation with Helicobacter pylori infection. Minerva Cardioangiol. 2000;48:467–473.
    1. Parente F, Bianchi Porro G. Helicobacter pylori infection and ischaemic heart disease: is there a link? Ital J Gastroenterol Hepatol. 1998;30:119–123.
    1. Cammarota G. et al. Helicobacter pylori infection and ischaemic heart disease. Ital J Gastroenterol Hepatol. 1998;30:304–306.
    1. Cammarota G, Pasceri V, Gasbarrini A, Gasbarrini G. Helicobacter pylori is an aetiological factor for ischaemic heart disease: the case against. Dig Liver Dis. 2000;32:65–68.
    1. Pieniazek P, Karczewska E, Duda A, Tracz W, Pasowicz M, Konturek SJ. Association of Helicobacter pylori infection with coronary heart disease. J Physiol Pharmacol. 1999;50:743–751.
    1. Fagoonee S, De Angelis C, Elia C, Silvano S, Oliaro E, Rizzetto M, Pellicano R. Potential link between Helicobacter pylori and ischemic heart disease: does the bacterium elicit thrombosis? Minerva Med. 2010;101:121–125.
    1. Strachan DP. Non-gastrointestinal consequences of Helicobacter pylori infection. Br Med Bull. 1998;54:87–93.
    1. Zhu J, Katz RJ, Quyyumi AA, Canos DA, Rott D, Csako G. et al. Association of serum antibodies to heat-shock protein 65 with coronary calcification levels: suggestion of pathogen-triggered autoimmunity in early atherosclerosis. Circulation. 2004;109:36–41.
    1. Martinez Torres A, Martinez Gaensly M. Helicobacter pylori: a new cardiovascular risk factor? Rev Esp Cardiol. 2002;55:652–656.
    1. Saikku P, Leinonen M, Tenkanen L, Linnanmäki E, Ekman MR, Manninen V. et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med. 1992;116:273–278.
    1. Hara K, Morita Y, Kamihata H, Iwasaka T, Takahashi H. Evidence for infection with Helicobacter pylori in patients with acute myocardial infarction. Clin Chim Acta. 2001;313:87–94.
    1. Zhu J, Nieto FJ, Horne BD, Anderson JL, Muhlestein JB, Epstein SE. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation. 2001;103:45–51.
    1. Niemelä S, Karttunen T, Korhonen T, Läärä E, Karttunen R, Ikäheimo M, Kesäniemi YA. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart. 1996;75:573–575.
    1. Lip GH, Wise R, Beevers G. Association of Helicobacter pylori infection with coronary heart disease. Study shows association between H pylori infection and hypertension. Br Med J. 1996;312:250–251.
    1. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. Br Med J. 1998;316:1130–1132.
    1. Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease and stroke in middle-aged men. Heart. 1997;77:294.
    1. Smieja M, Gnarpe J, Lonn E, Gnarpe H, Olsson G, Yi Q. et al. Heart Outcomes Prevention Evaluation (HOPE) study investigators. Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation. 2003;107:251–257.
    1. Rupprecht HJ, Blankenberg S, Bickel C, Rippin G, Hafner G, Prellwitz W. et al. AutoGene Investigators. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation. 2001;104:25–31.
    1. Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men. Heart. 1996;75:568–572.
    1. Coles KA, Knuiman MW, Plant AJ, Riley TV, Smith DW, Divitini ML. A prospective study of infection and cardiovascular diseases: the Busselton Health Study. Eur J Cardiovasc Prev Rehabil. 2003;10:278–282.
    1. Pellicano R, Oliaro E, Gandolfo N, Aruta E, Mangiardi L, Orzan F. et al. Ischemic cardiovascular disease and Helicobacter pylori. Where is the link? J Cardiovasc Surg (Torino) 2000;41:829–833.
    1. Tsai CJ, Huang TY. Relation of Helicobacter pylori infection and angiographically demonstrated coronary artery disease. Dig Dis Sci. 2000;45:1227–1232.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren